Cargando…

2446. Effect of the Implementation of a Fluconazole Prophylaxis Protocol on the Incidence of Invasive Fungal Infection in High-Risk Neonates

BACKGROUND: Invasive fungal infection (IFI) is one of the most important causes of morbidity and mortality in the neonatal intensive care unit. International societies have supported the use of fluconazole prophylaxis for neonates weighing < 1000 grams, but administration to other high-risk patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isada, Patricia Marie D, Pagcatipunan, Marimel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679045/ http://dx.doi.org/10.1093/ofid/ofad500.2064

Ejemplares similares

2446. Clinical Spectrum and Outcomes of Colistin-Resistant Carbapenem-Resistant Enterobacteriaceae
por: Ahmed, Sara, et al.
Publicado: (2018)

2446. Longitudinal Results and Cost Savings Using a Bundle of C. difficile Infection Prevention Strategies in a Long-Term Care Facility
por: Olson, Bridget A, et al.
Publicado: (2019)

Incidence of candidemia before and after fluconazole prophylaxis implementation in a 14-bed general ICU
por: Vartzeli, P, et al.
Publicado: (2008)

2106. Evaluation of Isavuconazole for the Prophylaxis and Treatment of Invasive Fungal Infections at a Large Academic Medical Center
por: Vu, Christine, et al.
Publicado: (2019)

Fluconazole prophylaxis for prevention of invasive candidiasis in extremely preterm infants
por: Kim, Chun Soo
Publicado: (2020)

The efficacy and safety of nirsevimab for the prevention of RSV infection among infants: A systematic review and meta-analysis
por: Turalde-Mapili, Maria Wilma R., et al.
Publicado: (2023)

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
por: Vuichard, Danielle, et al.
Publicado: (2014)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

The effectiveness of hepa filtered rooms plus fluconazol prophylaxis for preventation of invasive fungal diseases in allogenic stem cell transplant patients
por: Kurkcuoglu, C Altay, et al.
Publicado: (2015)

2884. Incidence of Invasive Fungal Infections After Pancreas Transplantation
por: Nair, Vaisak, et al.
Publicado: (2023)

2736. Real-world Effectiveness of Posaconazole Prophylaxis in Preventing Invasive Fungal Infections in Recipients of Allogeneic Stem Cell Transplantation
por: Álvarez-Ortega, Carolina, et al.
Publicado: (2023)

Prophylaxis of Invasive Fungal Infection in Neonates: A Narrative Review for Practical Purposes
por: Ferrando, Giulia, et al.
Publicado: (2023)

Oral Nystatin Versus Intravenous Fluconazole as Neonatal Antifungal Prophylaxis: Non-inferiority Trial
por: Mersal, Ali, et al.
Publicado: (2013)

971. Breakthrough Invasive Fungal Infections (IFI) in Acute Leukemia (AL) Patients Receiving Antifungal Prophylaxis
por: Wasylyshyn, Anastasia, et al.
Publicado: (2018)

2885. Increased incidence of fluconazole-resistant Candida parapsilosis bloodstream infections in Atlanta, Georgia 2021
por: Witt, Lucy S, et al.
Publicado: (2023)

Fluconazole prophylaxis of systemic candida infection in non-neutropenic critically ill patients: a prospective randomized study
por: Parizkova, R, et al.
Publicado: (1999)

2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
por: Shulkosky, Megan, et al.
Publicado: (2023)

Clinical Outcomes of the Oral Suspension vs Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections
por: Tallman, Gregory B, et al.
Publicado: (2017)

Problem Based Learning (PBL) in an Infectious Diseases Fellowship
por: Isada, Carlos, et al.
Publicado: (2017)

Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled trials
por: Che, Datian, et al.
Publicado: (2016)

941. Isavuconazole Prophylaxis Against Invasive Fungal Infection: A Pooled Analysis with a Comparison of Posaconazole Delayed-release Tablet Prophylaxis
por: Lee, Chaeryoung, et al.
Publicado: (2021)

Primary or Secondary Prophylaxis with Voriconazole Compared with Posaconazole for Prevention of Invasive Fungal Infections After Hematopoietic Stem Cell Transplantation
por: Jansen, Jeffrey W, et al.
Publicado: (2017)

Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis
por: Breitkopf, Robert, et al.
Publicado: (2023)

Chemoprophylaxis of Neonatal Fungal Infections in Very Low Birth Weight Infants: Efficacy and Safety of Fluconazole and Nystatin
por: Al-Alaiyan, Saleh
Publicado: (2012)

Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study
por: Zilberberg, Marya, et al.
Publicado: (2014)

2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

1736. Evaluation of Targeted vs. Universal Antifungal Prophylaxis (AP) for Invasive Fungal Infections (IFI) After Lung Transplant (LTx)
por: Linder, Kathleen A, et al.
Publicado: (2019)

P496 Effect of fluconazole prophylaxis in prevention of local fungal infections in patients of head and neck cancers receiving chemo-radiotherapy
por: Lohia, Shashwat, et al.
Publicado: (2022)

Fluconazole prophylaxis in preterm infants: a systematic review
por: Rios, Juliana Ferreira da Silva, et al.
Publicado: (2017)

Fluconazole prophylaxis against invasive candidiasis in very low and extremely low birth weight preterm neonates: a systematic review and meta-analysis
por: Robati Anaraki, Mahmoud, et al.
Publicado: (2020)

The Role of Fluconazole Prophylaxis Regimen and the Regimes Chosen by the Patient’s Risk of Fungal Infection in Reducing the Infection Rate after Bone Marrow Transplantation
por: Pourghasemian, Mehdi, et al.
Publicado: (2018)

A Cluster of Fluconazole-Resistant Malassezia pachydermatis in a Neonatal Intensive Care Unit — California, 2015–2016
por: Chinn, Raymond, et al.
Publicado: (2017)

Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
por: Oh, Sang-Min, et al.
Publicado: (2021)

1086. Epidemiology, Risk Factors, and Effect of Antifungal Prophylaxis on Early Invasive Fungal Infection in Heart Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2020)

The relationship between the use of fluconazole & the incidence of fluconazole-resistant Candida species
por: Kuo, Chia-Chang, et al.
Publicado: (2014)

1996. Invasive Fungal Infections in Orthotopic Heart Transplant: Incidence and Risk Factors in the Modern Era
por: Hasan, Lana, et al.
Publicado: (2023)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

2117. Fluconazole vs. Echinocandins as Initial Therapy for Candidemia Caused by Fluconazole-Susceptible Species in the Era of Rapid Diagnostic Testing
por: Roshdy, Danya, et al.
Publicado: (2019)

2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes
por: Kovac, Victor, et al.
Publicado: (2023)

376. Predictive Model for Fluconazole Resistance in Patient With Candida Bloodstream Infection
por: Aljorayid, Abdullah, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9ip6lkmi1ljhuq6s7lsr3r1fe4